Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKutanış, Dilek
dc.contributor.authorErtürk, Engin
dc.contributor.authorBeşir, Ahmet
dc.contributor.authorDemirci, Yücel
dc.contributor.authorKayır, Selçuk
dc.contributor.authorAkdoğan, Ali
dc.contributor.authorVanizor Kural, Birgül
dc.contributor.authorBahat, Zümrüt
dc.contributor.authorCanyılmaz, Emine
dc.contributor.authorKara, Hanife
dc.date.accessioned2019-05-13T08:58:19Z
dc.date.available2019-05-13T08:58:19Z
dc.date.issued2016
dc.identifier.citationKutanış, D., Ertürk, E., Beşir, A., Demirci, Y., Kayır, S., Akdoğan, A., Vanizor Kural, B., Bahat, Z. [et.al.].(2016). Dexmedetomidine acts as an oxidative damage prophylactic in rats exposed to ionizing radiation. Journal of Clinical Anesthesia, 34, 577-585.en_US
dc.identifier.issn0952-8180
dc.identifier.urihttps://doi.org/10.1016/j.jclinane.2016.06.031
dc.identifier.urihttps://hdl.handle.net/11491/1112
dc.description.abstractStudy objective To investigate the effects of dexmedetomidine on oxidative injury caused by ionizing radiation. Design Randomized controlled experimental study. Setting Department of radiation oncology and research laboratory of an academic hospital. Interventions Twenty-eight rats were randomized to 4 groups (n = 7 per group). Group S rats were administered physiologic serum; group SR rats were administered physiologic serum and 10 Gy external ionizing radiation. Groups D100 and D200 were administered 100 and 200 ?g/kg dexmedetomidine intraperitoneally, respectively, 45 minutes before ionizing radiation. Measurements Liver, kidney, lung, and thyroid tissue and serum levels of antioxidant enzymes (glutathione peroxidase [GPX], superoxide dismutase, and catalase) and oxidative metabolites (advanced oxidation protein products, malondialdehyde, and nitrate/nitrite, and serum ischemia-modified albumin) were measured 6 hours postprocedure. Main results In group SR, IR decreased antioxidant enzyme levels and increased oxidative metabolite levels (P < .05). In plasma, antioxidant enzyme levels were higher and oxidative metabolite levels were lower in groups D100 and D200 than in group SR (P < .01). In tissues, hepatic and lung GPX levels were higher in groups D100 and D200 than in group SR (P < .001). Renal and thyroid GPX levels were higher in D200 than in group SR (P < .01). Thyroid superoxide dismutase levels were higher in groups D100 and D200 than in group SR (P < .01). Renal, lung, and thyroid catalase levels were higher in group D200 than in group SR (P < .01). Hepatic, renal, and lung advanced oxidation protein products and malondialdehyde levels were lower in groups D100 and D200 than in group SR (P < .01). Hepatic, renal, and lung nitrate/nitrite levels were lower in group D200 than in group SR (P < .05). Conclusions Dexmedetomidine preserves the antioxidant enzyme levels and reduces toxic oxidant metabolites. Therefore, it can provide protection from oxidative injury caused by ionizing radiation. © 2016 Elsevier Inc.en_US
dc.language.isoeng
dc.publisherElsevier Inc.en_US
dc.relation.isversionof10.1016/j.jclinane.2016.06.031en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDexmedetomidineen_US
dc.subjectIonizing Radiationen_US
dc.subjectOxidative Damageen_US
dc.titleDexmedetomidine acts as an oxidative damage prophylactic in rats exposed to ionizing radiationen_US
dc.typearticleen_US
dc.relation.journalJournal of Clinical Anesthesiaen_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.identifier.volume34en_US
dc.identifier.startpage577en_US
dc.identifier.endpage585en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster